栓塞剂

血管内新型液体栓塞剂CAP的实验研究

Experimental study on a new endovascular liquid embolic agent cellulose acetate polymer

使用PVA微粒为栓塞剂的部分性脾栓塞术

Partial Splenic Embolization Using PVA Particles as Embolic Agent

方法采用经皮股动脉穿刺插管法，用惰性聚乙烯醇颗粒（PVA）作为栓塞剂，选择性子宫动脉栓塞治疗6例子宫肌瘤患者。

Methods Six patients underwent selective uterine artery embolization with PVA .

血管栓塞剂选用钢圈、明胶海绵、PVA微粒三种。

The vascular embolic agents include steel coil , gelfoam , and PVA .

聚丙烯腈（PAN）可作为一种新型的治疗用栓塞剂。

Preparations of polyacrylonitrile ( PAN ) are now being considered as possible new therapeutic embolization agents .

方法：对54例子宫肌瘤患者采用经股动脉穿刺插管法，用PVA作为栓塞剂，进行选择性子宫动脉栓塞治疗。

Method Fifty-four patients with uterine myoma were selected for uterine arteries embolization with the PVA .

结论对于头面部动静脉畸形的患者来说，经导管栓塞术是一种较好的非手术治疗方法，在栓塞剂的选择方面，则以PVA微粒栓塞更为理想。

Conclusion Transcatheter artery embolization is a effective method to AVM . PVA is more suitable opposite to TH glue .

APA介入显影栓塞剂治疗脑动静脉畸形

APA Intervention Developing Embolic Agent in Cerebrovascular Deformity

目的研制一种血管内治疗颅内动脉瘤的液体栓塞剂&醋酸纤维素聚合物（CAP）。

Objective To research the cellulose acetate polymer ( CAP ) solution which was used as a new liquid thrombotic material for endovascular treatment of intracranial aneurysm .

液体栓塞剂Onyx在脑动静脉畸形治疗中的探索

Liquid embolic agent Onyx in the treatment of cerebral arteriovenous malformations

目的观察实验性宽颈动脉瘤被非黏附性液体栓塞剂醋酸纤维素聚合物（CAP）栓塞后的组织学变化。

Objective To observe the histological changes of the experimental wide-neck aneurysms embolized with cellulose acetate polymer ( CAP ) - a kind of non-adhesive liquid embolic material .

应用Onyx液态栓塞剂治疗脑动静脉畸形的探讨

Investigation of the treatment of brain arteriovenous malformation with Onyx

而常规TACE术疗效主要取决于栓塞剂的选择及对肿瘤供血动脉的栓塞程度。

The efficacy of conventional TACE procedure depends on the choice of embolic agents and the degree of tumor-feeding artery embolization .

目前最常用的栓塞剂仍然是NBCA。

The most commonly used agent is still NBCA currently .

目的探讨用血管栓塞剂TH胶作肾上腺静脉栓塞治疗肾上腺功能亢进性疾病的可行性。

Objective Probe into the possibility that the TH glue ( N-octyl - α - cyanaocrylate ) , as an adrenal veins occlusive agent to treat the diseases of adrenal hyperfunction .

方法36例子宫肌瘤患者，随机分为3组，采用与碘油不同栓塞剂组合，行双侧子宫动脉栓塞（UAE）治疗。

Methods 36 cases of hysteromyoma were divided randomly into 3 groups and treated with uterine artery embolization ( UAE ) .

新型液态栓塞剂（Onyx）栓塞脑动静脉畸形28例临床分析

Embolization of Cerebral Arteriovenous Malformations with A New Liquid Embolic Agent ( Onyx ): Clinical Experience in 28 cases

目的探讨非粘附性液体栓塞剂Onyx栓塞治疗脑动静脉畸形的可行性和安全性。方法采用Onyx液体栓塞剂栓塞24例脑动静脉畸形，并对血管内治疗效果和手术的注意事项进行分析。

Objective To study the feasibility and safety of embolization of cerebral arteriovenous malformations with non-adhesive liquid embolic agent-Onyx .

血管内栓塞剂为NBCA，栓后显微外科手术切除。

Embolic agent was NBCA .

结论咯血患者BAE治疗后复发出血与栓塞剂的选择、栓塞技术及基础疾病有关。

Conclusion The recurrent emptysis after BAE is related to the choice of embolic agents , interventional techniques and underlying diseases .

方法：采用seldinger技术，经皮股动脉插管进行肝动脉灌注化疗药物加栓塞剂。

Methods : Transcatheteral hepatic artery perfusion of chemotherapeutic and embol-ic agents via femoral artery was performed by Seldinger technique .

目前临床上应用最多的是液体胶栓塞剂，包括NBCA胶和Onyx胶。

For now , the NBCA glue and Onyx glue are the most common liquid glue embolic materials in clinical .

目的：探讨应用液态栓塞剂Onyx栓塞治疗脑动静脉畸形（AVM）的技术方法和临床意义。

Objective : To explore the clinical significance of a liquid embolic agent Onyx in the treatment of cerebral arteriovenous malformations ( AVMs ) .

结论NBCA为永久性栓塞剂，应作为栓塞治疗颅内AVM的首选材料。

Conclusions The embolization of intracranial AVMs with NBCA is safe and effective . NBCA is considered as the first choice embolization material .

栓塞剂选用05～15mm3明胶海绵颗粒30～50颗和（或）超液态碘油3～8ml。

30-50 Gelfoam particles and / or 3-8 ml Lipiodol was used as embolic material .

结论：①IBCA和NBCA可做永久性栓塞剂；

Conclusion : ( 1 ) IBCA and NBCA can be used as permanent embolic agent .

栓塞剂由150mg明胶海绵和10ml40%的碘化油所组成。

Embolization was done with 150 mg gelatin sponge ( Gelfoam ) and 10 ml of 40 % iodized oil .

目的介绍新型液态栓塞剂Onyx栓塞脑动静脉畸形的技术要点和临床疗效。

Objective To report the embolization techniques and efficacy of cerebral arteriovenous malformations ( AVMs ) using a new liquid embolic agent ( Onyx ) .

目的探讨新型栓塞剂海藻酸钠微球（KMG）应用于子宫动脉栓塞术（UAE）治疗子宫肌瘤的近期临床疗效及不良反应。

Objective To study the efficacy and side effects of sodium alginate ( KMG ), a new embolismic agent used in uterine artery embolism ( UAE ) for treating uterine myoma .

治疗方案为FAM（5-氟尿嘧啶、阿霉素或表阿霉素、丝裂霉素）或FPM（5-氟尿嘧啶、顺铂或卡铂、丝裂霉素），栓塞剂为超液化碘油。

Chemotherapy was carried out with FAM regimen ( 5-fluorouracil , mitomycin and adriamycin or epirubicin ) or FPM regimen ( 5-fluorouracil , mitomycin and cisplatin or carboplatin ) . Ultra-fluid lipiodol was used for embolization .